Vu Quan Anh 4
4 · Monopar Therapeutics · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Vu Quan Anh
Chief Financial Officer
Transactions
- Award
Stock Options
2025-03-03+25,000→ 25,000 totalExercise: $30.93Exp: 2035-03-02→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]On March 3, 2025, the reporting person was granted 25,000 stock options, vesting 6/48ths (15,625 shares) on September 2, 2025, and 1/48th every month thereafter until the stock option is fully vested on March 3, 2029.